• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • EMBELIN
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ALLERGIES & CYTOKINES
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • AMPK
      • ANTI AGING
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • APOPTOSIS
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • BRASSINOSTEROIDS
      • CARDIAC GLYCOSIDES
      • CENTENARIANS
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DIABETES & CANCER
      • EPIGENETIC MODIFIERS
      • EXCITOXICITY & THE BRAIN
      • FGF21
      • FLAVONES
      • GLUTAMATE & BRAIN
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HMGB1
      • HORMESIS
      • HSP90 INHIBITORS
      • HYPERINSULINEMIA
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • IKK
      • IL-6/STAT3
      • IRISIN
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LIFESPAN EXTENSION
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MITOCHONDRIAL UNCOUPLING
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL AROMATASE INHIBITORS
      • NEUROINFLAMMATION
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR AND FEAR
      • NOOTROPICS
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SIRT1 & LONGEVITY
      • SUGAR & AGING
      • STAT3
      • TELOMERE SHORTENING & PREMATURE AGING
      • TRAUMATIC BRAIN INJURY (HEALING)
    • HOME
    • FAQ
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    INSULIN & MTOR
    February 8, 2021
    POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
    February 9, 2021
    1. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration
    2. excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator
    3. Inflammatory cytokines IL-1α, IL-1β, IL-6, and TNF-α impart neuroprotection to an excitotoxin through distinct pathways
    4. Mitochondrial depolarization in glutamate-stimulated neurons: an early signal specific to excitotoxin exposure
    5. … dissociations of the effects of amygdala and insular cortex lesions on conditioned taste aversion, passive avoidance, and neophobia in the rat using the excitotoxin …
    6. L-cysteine, a bicarbonate-sensitive endogenous excitotoxin
    7. excitotoxin lesions in primates as a model for Huntington’s disease: histopathologic and neurochemical characterization
    8. A possible central mechanism in autism spectrum disorders, part 3: the role of excitotoxin food additives and the synergistic effects of other environmental toxins.
    9. The excitotoxin quinolinic acid induces tau phosphorylation in human neurons
    10. Nerve growth factor (NGF) regulates adult rat cultured dorsal root ganglion neuron responses to the excitotoxin capsaicin
    11. Activated human microglia produce the excitotoxin quinolinic acid
    12. The excitotoxin hypothesis in relation to cerebral ischemia.
    13. Cyclin-dependent kinase 4 and cyclin D1 are required for excitotoxin-induced neuronal cell death in vivo
    14. … , a cAMP-Specific Phosphodiesterase-4 Inhibitor, Reduces Oxidative Stress and Improves Synapse Functions in Human Cortical Neurons Exposed to the excitotoxin …
    15. excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area
    16. Glutamate‐mediated injury in focal cerebral ischemia: the excitotoxin hypothesis revised
    17. Glucocorticoids worsen excitotoxin-induced expression of pro-inflammatory cytokines in hippocampal cultures
    18. Changes in Cathepsin D and Beclin-1 mRNA and protein expression by the excitotoxin quinolinic acid in human astrocytes and neurons
    19. Reactive microglia and IL1β/IL-1R1-signaling mediate neuroprotection in excitotoxin-damaged mouse retina
    20. Nuclear factor-κB contributes to excitotoxin-induced apoptosis in rat striatum
    21. Differential sparing of somatostatin‐neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions
    22. Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys
    23. Cellular mechanism of action of resiniferatoxin: a potent sensory neuron excitotoxin
    24. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans
    25. Enhanced cellular glutathione peroxidase immunoreactivity in activated astrocytes and in microglia during excitotoxin induced neurodegeneration
    26. Tissue-type plasminogen activator protects neurons from excitotoxin-induced cell death via activation of the ERK 1/2–CREB–ATF3 signaling pathway
    27. Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene
    28. Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral …
    29. A caspase‐3‐dependent pathway is predominantly activated by the excitotoxin pregnenolone sulfate and requires early and late cytochrome c release and cell …
    30. Chronic excitotoxin-induced axon degeneration in a compartmented neuronal culture model
    31. Short-and long-term consequences of intracranial injections of the excitotoxin, quinolinic acid, as evidenced by GFA immunohistochemistry of astrocytes
    32. Contribution of ventral tegmental area dopamine neurons to expression of conditional fear: effects of electrical stimulation, excitotoxin lesions, and quinpirole infusion …
    33. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington’s disease
    34. Induction of β-amyloid-containing polypeptides in hippocampus: evidence for a concomitant loss of synaptic proteins and interactions with an excitotoxin
    35. Evidence for activation of caspase‐3‐like protease in excitotoxin‐and hypoxia/hypoglycemia‐injured neurons
    36. Gonadal hormones affect neuronal vulnerability to excitotoxin-induced degeneration
    37. Neurochemical characterization of excitotoxin lesions in the cerebral cortex
    38. The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging process
    39. Proteomic identification of hippocampal proteins vulnerable to oxidative stress in excitotoxin-induced acute neuronal injury
    40. The HDAC6 inhibitor trichostatin A acetylates microtubules and protects axons from excitotoxin-induced degeneration in a compartmented culture model
    41. Aminooxyacetic acid results in excitotoxin lesions by a novel indirect mechanism
    42. PARP cleavage, DNA fragmentation, and pyknosis during excitotoxin-induced neuronal death
    43. The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain
    44. excitotoxin-mediated neuron death in youth and old age
    45. excitotoxin paraventricular nucleus lesions: stress and endocrine reactivity and oxytocin mRNA levels
    46. Quercetin attenuates oxygen–glucose deprivation-and excitotoxin-induced neurotoxicity in primary cortical cell cultures
    47. Rod bipolar cells dysfunction occurs before ganglion cells loss in excitotoxin-damaged mouse retina
    48. excitotoxin-induced caspase-3 activation and microtubule disintegration in axons is inhibited by taxol
    49. What excitotoxin kills striatal neurons in Huntington’s disease? Clues from neurochemical studies
    50. Glucocorticoid protection of oligodendrocytes against excitotoxin involving hypoxia-inducible factor-1α in a cell-type-specific manner
    51. Overexpression of neurotrophin receptor p75 contributes to the excitotoxin-induced cholinergic neuronal death in rat basal forebrain
    52. Nerve growth factor selectively prevents excitotoxin induced degeneration of striatal cholinergic neurones
    53. Sources of reactive oxygen species production in excitotoxin-stimulated cerebellar granule cells
    54. Age-related changes in tolerance to the marine algal excitotoxin domoic acid
    55. Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration
    56. The Lathyrus excitotoxin β-N-oxalyl-l-α, β-diaminopropionic acid is a substrate of the l-cystine/l-glutamate exchanger system xc−
    57. Induction of tumor suppressor p53 and DNA fragmentation in organotypic hippocampal cultures following excitotoxin treatment
    58. Brain and retinal damage from lathyrus excitotoxin, β-N-oxalyl-L-α, β-diaminopropionic acid
    59. Movement disorder following excitotoxin lesions in primates.
    60. Neuronal and nonneuronal COX‐2 expression confers neurotoxic and neuroprotective phenotypes in response to excitotoxin challenge
    61. Cyclophilin-A is involved in excitotoxin-induced caspase activation in rat neuronal B50 cells
    62. Moderately delayed post-insult treatment with normobaric hyperoxia reduces excitotoxin-induced neuronal degeneration but increases ischemia-induced …
    63. Behavioral disinhibition following basal forebrain excitotoxin lesions: alcohol consumption, defensive aggression, impulsivity and serotonin levels
    64. Iron‐mediated oxidation of 3, 4‐dihydroxyphenylalanine to an excitotoxin
    65. Potential mechanism of cellular uptake of the excitotoxin quinolinic acid in primary human neurons
    66. Strain differences in convulsive response to the excitotoxin kainic acid.
    67. Safranal attenuates excitotoxin-induced oxidative OLN-93 cells injury
    68. Increased levels of the excitotoxin quinolinic acid in spinal cord following contusion injury
    69. Hypoxia-ischemia or excitotoxin-induced tissue plasminogen activator-dependent gelatinase activation in mice neonate brain microvessels
    70. Calcium influx accompanies but does not cause excitotoxin-induced neuronal necrosis in retina
    71. Hippocalcin protects hippocampal neurons against excitotoxin damage by enhancing calcium extrusion
    72. Pregnenolone sulfate, a naturally occurring excitotoxin involved in delayed retinal cell death
    73. The effects of excitotoxin lesions of the lateral hypothalamus on self-stimulation reward
    74. Co-stimulation of cyclic-AMP-linked metabotropic glutamate receptors in rat striatum attenuates excitotoxin-induced nuclear factor-κB activation and apoptosis
    75. excitotoxin lesions do not mimic the alteration of somatostatin in Huntington’s disease
    76. Protection by MK-801 against hypoxia-, excitotoxin-, and depolarization-induced neuronal damage in vitro
    77. excitotoxin lesions of the zona incerta/lateral tegmentum continuum: effects on male sexual behavior in rats
    78. 3-Nitropropionic acid is an indirect excitotoxin to cultured cerebellar granule neurons
    79. Variation in Galr1 expression determines susceptibility to excitotoxin‐induced cell death in mice
    80. excitotoxin‐Induced Neuronal Death Is Associated with Response of a Unique Intracellular Aspartic Proteinase, Cathepsin E
    81. Differences in ionotropic glutamate receptor subunit expression are not responsible for strain-dependent susceptibility to excitotoxin-induced injury
    82. Induction of Ornithine Decarboxylase in Cerebral Cortex by excitotoxin Lesion of Nucleus Basalis: Association with Postsynaptic Responsiveness and N‐Methyl‐d …
    83. The direction of apomorphine-induced rotation behavior is dependent on the location of excitotoxin in the rat basal ganglia
    84. Comparison of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [18 F] PBR102 and [18 F] PBR111 in a model of excitotoxin-induced …
    85. Microtubule‐dependent processes precede pathological calcium influx in excitotoxin‐induced axon degeneration
    86. Lathyrus excitotoxin: mechanism of neuronal excitation by L-2-oxalylamino-3-amino-and L-3-oxalylamino-2-amino-propionic acid
    87. … of glia‐derived nexin/protease nexin 1 depends on mode of lesion‐induction or terminal degeneration: Observations after excitotoxin or 6‐hydroxydopamine lesions …
    88. GM1 ganglioside protects nucleus basalis from excitotoxin damage: reduced cortical cholinergic losses and animal mortality
    89. Effects of excitotoxin exposure on metabolic rate of primary hippocampal cultures: application of silicon microphysiometry to neurobiology
    90. Patterns of excitotoxin-induced brain lesions in the newborn rabbit: a neuropathological and MRI correlation
    91. Alterations in behavioral responses to stressors following excitotoxin lesions of dorsomedial hypothalamic regions
    92. Long-term sensitization of apomorphine-induced rotation behavior in rats with dopamine deafferentation or excitotoxin lesions of the striatum
    93. NO-flurbiprofen attenuates excitotoxin-induced brain inflammation, and releases nitric oxide in the brain
    94. Effect of excitotoxin lesions in the medial prefrontal cortex on cortical and subcortical catecholamine turnover in the rat
    95. Magnetic resonance imaging to monitor pathology of caudate-putamen after excitotoxin-induced neuronal loss in the nonhuman primate brain
    96. excitotoxin-induced myocardial necrosis
    97. TOPA quinone, a kainate-like agonist and excitotoxin is generated by a catecholaminergic cell line
    98. Effects of antenatal uteroplacental hypoperfusion on neonatal microvascularisation and excitotoxin sensitivity in mice
    99. Alterations in Extracellular Amino Acids and Ca2+ Following excitotoxin Administration and During Status Epilepticus
    100. Induction of c-fos mRNA in cerebral cortex by excitotoxin stimulation of cortical inputs: involvement ofN-methyl-d-aspartate receptors
    101. Distribution of neuropeptide Y immunoreactivity in the rat basal ganglia: effects of excitotoxin lesions to caudate-putamen
    102. Fetal striatal tissue grafts into excitotoxin-lesioned striatum: pharmacological and behavioral aspects
    103. In vitro culture duration does not impact the ability of encapsulated choroid plexus transplants to prevent neurological deficits in an excitotoxin-lesioned rat model of …
    104. excitotoxin-induced lesions of the central but not basolateral nucleus of the amygdala modulate the baroreceptor heart rate reflex in conscious rats
    105. Recombinant human ciliary neurotrophic factor alters the threshold of hippocampal pyramidal neuron sensitivity to excitotoxin damage: synergistic effects of …
    106. T1 and T2 weighted magnetic resonance imaging of excitotoxin lesions and neural transplants in rat brain in vivo
    107. L-trans-2, 3-pyrrolidine dicarboxylate: characterization of a novel excitotoxin
    108. 6-Hydroxydopamine and excitotoxin lesions of medial prefrontal cortex fail to affect schedule-induced drinking in the rat
    109. Is quinolinic acid an endogenous excitotoxin in alcohol withdrawal?
    110. The calcium response to the excitotoxin kainate is amplified by subsequent reduction of extracellular sodium
    111. Quantitative morphometric analysis of the neurotoxic effects of the excitotoxin, ibotenic acid, on the basal forebrain.
    112. Receptor interactions of β-N-oxalyl-L-α, β-diaminopropionic acid, the Lathyrus sativus putative excitotoxin, with synaptic membranes
    113. The NMDA receptor agonist DL-(tetrazol-5-yl) glycine is a highly potent excitotoxin
    114. Crude and Partition Extracts of Newbouldia laevis Leaves Attenuate excitotoxin-induced Stereotypy in Mice
    115. Effect of fetal striatal and astrocyte transplants into unilateral excitotoxin-lesioned striatum
    116. Low dose quetiapine reverses deficits in contextual and cued fear conditioning in rats with excitotoxin-induced hippocampal neuropathy
    117. excitotoxin-induced cerebral hyperemia in newborn piglets: regional cerebral blood flow mapping with contrast-enhanced power Doppler US.
    118. Effects of nigral dopaminergic lesions and striatal excitotoxin lesions on brain converting enzyme
    119. excitotoxin-induced degeneration of rat vagal afferent neurons
    120. Differential temporal patterns of expression of immediate early genes in cerebral cortex induced by intracerebral excitotoxin injection: sensitivity to dexamethasone …
    121. Ultrastructural and immunocytochemical studies of macrophages in an excitotoxin induced lesion in the rat brain.
    122. … and anatomical analysis of cholinergic, noradrenergic and serotonergic innervation of fetal neocortical transplants placed in excitotoxin-induced neocortical lesions of …
    123. excitotoxin-induced changes in transglutaminase during differentiation of cerebellar granule cells
    124. Synthesis and pharmacology of N-alkylated derivatives of the excitotoxin ibotenic acid
    125. Local and remote microvascular changes in excitotoxin-induced focal brain lesions
    126. 6-Hydroxydopa, a catecholamine neurotoxin and endogenous excitotoxin at non-NMDA receptors
    127. ATP as a marker of excitotoxin-induced nerve cell death in vivo
    128. Immuno-electron microscopy reveals that the excitotoxin quinolinate is associated with the plasma membrane in human peripheral blood monocytes/macrophages
    129. Central administration of the excitotoxin N-methyl-D-aspartate increases nerve growth factor mRNA in vivo.
    130. Role of Group III Metabotropic Glutamate Receptors in excitotoxin‐Induced Cerebellar Granule Cell Death
    131. Expression of c-fos mRNA and c-fos protein in neocortical transplants placed into excitotoxin-induced lesions in adult rats
    132. excitotoxin lesion of nucleus basalis causes a specific decrease in Go mRNA in cerebral cortex: sensitivity to MK-801
    133. excitotoxin induction of ornithine decarboxylase in cerebral cortex is reduced by phospholipase A2 inhibition
    134. excitotoxin mediated neuronal loss and the regulation of excitatory amino acid release in the aging brain
    135. Depletion of cortical cholecystokinin levels after excitotoxin injection into the nucleus basalis: sensitivity to MK-801
    136. Neuronal damage in the albino rat: excitotoxin, microtubule inhibitor synergism
    137. Differential effects of dexamethasone on the induction of c-fos, zif-268 and ornithine decarboxylase by excitotoxin
    138. Neuroprotective Effects of a Variety of Pomegranate Juice Extracts (PJE) Against the excitotoxin Quinolinic Acid in Human Primary Neurons.
    139. excitotoxin-lesioned rat striatum
    140. Macrophage-microglia responses to excitotoxin-induced degeneration in the central nervous system
    141. Effect of selective excitatory amino acid antagonists on excitotoxin-induced changes in APP mRNA expression
    142. Mechanisms of Zn2+-and excitotoxin-induced oligodendrocyte progenitor cell injury.
    143. The role of metabotropic receptors in excitotoxin-induced rat cerebellar granule cell death
    144. Evidence for the endogenous formation of the excitotoxin TOPA quinone.
    145. 47. Noradrenaline re-uptake inhibition influences neuroinflammatory and degenerative changes associated with the excitotoxin kainic acid
    146. MECHANISMS OF KAINIC ACID INDUCED HIPPOCAMPAL EPILEPSY (GLUTAMIC ACID DECARBOXYLASE, excitotoxin, NEUROTOXICOLOGY).
    147. The excitotoxin Elimination Diet: A Novel Dietary Intervention for those with Fibromyalgia and Irritable Bowel Syndrome
    148. Upregulation of hippocampal Senescence marker protein 30 in response to excitotoxin is involved in the ERK-mediated activation of astrocytes
    149. MSG (Monosodium Glutamate): The Flavor Enhancing excitotoxin Linked to Obesity, Brain Damage and other Diseases
    150. Pretreatment of curcumin protects hippocampal neurons against excitotoxin-induced cell death
    151. Variation in Galr1 expression determines the susceptibility to excitotoxin-induced neuronal death in mice
    152. EVALUATION OF excitotoxin RECEPTORS
    153. excitotoxic and excitoprotective mechanisms
    154. excitotoxic cell death
    155. Alternative excitotoxic hypotheses
    156. II. excitotoxic models for neurodegenerative disorders
    157. Calcium and excitotoxic neuronal injury
    158. Inciting excitotoxic cytocide among central neurons
    159. excitotoxic mechanisms of epileptic brain damage.
    160. Progression of ischaemic stroke and excitotoxic aminoacids
    161. excitotoxic amino acids and neuropsychiatric disorders.
    162. Requirement for superoxide in excitotoxic cell death
    163. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches
    164. excitotoxic injury of the neostriatum: a model for Huntington’s disease
    165. NBQX attenuates excitotoxic injury in developing white matter
    166. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
    167. Glutamate receptors and the induction of excitotoxic neuronal death
    168. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death
    169. Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions
    170. A revised excitotoxic hypothesis of schizophrenia: therapeutic implications
    171. β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage
    172. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models
    173. excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model
    174. Glioma cells release excitotoxic concentrations of glutamate
    175. Zinc and excitotoxic brain injury: a new model
    176. The link between excitotoxic oligodendroglial death and demyelinating diseases
    177. Molecular mechanisms underlying specificity of excitotoxic signaling in neurons
    178. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons
    179. Diffusion-weighted imaging of acute excitotoxic brain injury
    180. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture
    181. Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage
    182. Conditioned taste aversion in rats with excitotoxic brain lesions
    183. excitotoxic neuronal death in the immature brain is an apoptosis‐necrosis morphological continuum
    184. Mutant huntingtin enhances excitotoxic cell death
    185. excitotoxic neurodegeneration in Alzheimer disease: new hypothesis and new therapeutic strategies
    186. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis
    187. excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis.
    188. Models of white matter injury: comparison of infectious, hypoxic‐ischemic, and excitotoxic insults
    189. excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury
    190. Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults
    191. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors
    192. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?
    193. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain
    194. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid
    195. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of …
    196. Object recognition and location memory in monkeys with excitotoxic lesions of the amygdala and hippocampus
    197. The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions
    198. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice
    199. Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4
    200. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism
    201. Akt1 regulates a JNK scaffold during excitotoxic apoptosis
    202. Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway.
    203. excitotoxic index—a biochemical marker of selective vulnerability
    204. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor
    205. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection
    206. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage
    207. Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset.
    208. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge
    209. Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration
    210. Retrograde abolition of conditional fear after excitotoxic lesions in the basolateral amygdala of rats: absence of a temporal gradient.
    211. Age‐dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate
    212. Rethinking the excitotoxic ionic milieu: the emerging role of Zn 2+ in ischemic neuronal injury
    213. Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death
    214. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter
    215. excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement
    216. Transforming Growth Factor-β1-Mediated Neuroprotection against excitotoxic Injury in Vivo
    217. Intracellular calcium concentrations during” chemical hypoxia” and excitotoxic neuronal injury
    218. Comparing deficits following excitotoxic and contusion injuries in the thoracic and lumbar spinal cord of the adult rat
    219. excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis
    220. Activation of calpain I converts excitotoxic neuron death into a caspase-independent cell death
    221. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo
    222. Increased brain damage after stroke or excitotoxic seizures in melatonin‐deficient rats
    223. Effect of excitotoxic lesions of rat medial prefrontal cortex on spatial memory
    224. Dissociating context and space within the hippocampus: effects of complete, dorsal, and ventral excitotoxic hippocampal lesions on conditioned freezing and spatial …
    225. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar …
    226. Lack of the p50 subunit of nuclear factor-κB increases the vulnerability of hippocampal neurons to excitotoxic injury
    227. Inhibition of succinate dehydrogenase by malonic acid produces an “excitotoxic” lesion in rat striatum
    228. Cell cycle regulators in neuronal death evoked by excitotoxic stress: implications for neurodegeneration and its treatment
    229. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid β‐peptide
    230. Synaptic regeneration and functional recovery after excitotoxic injury in the guinea pig cochlea.
    231. Delayed mitochondrial dysfunction in excitotoxic neuron death: cytochrome c release and a secondary increase in superoxide production
    232. Both pre-and posttraining excitotoxic lesions of the basolateral amygdala abolish the expression of olfactory and contextual fear conditioning.
    233. Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain
    234. Distinct roles for sodium, chloride, and calcium in excitotoxic dendritic injury and recovery
    235. AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function
    236. Aggravation of acute ischemic stroke by hyperthermia is related to an excitotoxic mechanism
    237. Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus
    238. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain.
    239. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat
    240. CREB and NF-κB transcription factors regulate sensitivity to excitotoxic and oxidative stress induced neuronal cell death
    241. Selective excitotoxic degeneration of adult pig retinal ganglion cells in vitro
    242. Poly (ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death
    243. excitotoxic lesions of basal forebrain cholinergic neurons: effects on learning, memory and attention
    244. Behavioral effects of excitotoxic lesions of ventral medial prefrontal cortex in the rat are hemisphere-dependent
    245. Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats
    246. excitotoxic lesions of the amygdala fail to produce impairment in visual learning for auditory secondary reinforcement but interfere with reinforcer devaluation effects in …
    247. excitotoxic lesions of the prelimbic‐infralimbic areas of the rodent prefrontal cortex disrupt motor preparatory processes
    248. Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells
    249. β‐Amyloid neurotoxicity is mediated by a glutamate‐triggered excitotoxic cascade in rat nucleus basalis
    250. NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults
    251. Non‐NMDA and NMDA receptor‐mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis‐necrosis …
    252. Role of P2X7 Receptors in Ischemic and excitotoxic Brain Injury In Vivo
    253. The PSD95–nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death
    254. Carnosine protects against excitotoxic cell death independently of effects on reactive oxygen species
    255. A transforming growth factor-β antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury
    256. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine
    257. Thalamic retrograde degeneration following cortical injury: an excitotoxic process?
    258. The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the α2A-adrenoceptor subtype
    259. Cerebrospinal fluid studies in children with cerebral malaria: an excitotoxic mechanism?
    260. Dietary restriction stimulates BDNF production in the brain and thereby protects neurons against excitotoxic injury
    261. Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve
    262. Effects of selective excitotoxic lesions of the nucleus accumbens core, anterior cingulate cortex, and central nucleus of the amygdala on autoshaping performance in …
    263. Cell-permeant Ca2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo
    264. Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat
    265. excitotoxic lesions of the pedunculopontine tegmental nucleus produce contralateral hemiparkinsonism in the monkey
    266. Protective effect of parvalbumin on excitotoxic motor neuron death
    267. Post‐training excitotoxic lesions of the dorsal hippocampus attenuate forward trace, backward trace, and delay fear conditioning in a temporally specific manner
    268. Cellular defenses against excitotoxic insults
    269. Eugenol protects neuronal cells from excitotoxic and oxidative injury in primary cortical cultures
    270. Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation
    271. Asymmetrical motor behavior in rats with unilateral striatal excitotoxic lesions as revealed by the elevated body swing test
    272. Micromolar L-glutamate induces extensive apoptosis in an apoptotic-necrotic continuum of insult-dependent, excitotoxic injury in cultured cortical neurones
    273. On the excitotoxic properties of quinolinic acid, 2, 3-piperidine dicarboxylic acids and structurally related compounds
    274. A microtiter trypan blue absorbance assay for the quantitative determination of excitotoxic neuronal injury in cell culture
    275. Glial changes following an excitotoxic lesion in the CNS—I. Microglia/macrophages
    276. Effects of α2-Adrenoceptor Agonists on Perinatal excitotoxic Brain Injury: Comparison of Clonidine and Dexmedetomidine
    277. L-homocysteic acid: an endogenous excitotoxic ligand of the NMDA receptor
    278. Apolipoprotein E expression by neurons surviving excitotoxic stress
    279. Glial changes following an excitotoxic lesion in the CNS—II. Astrocytes
    280. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury
    281. Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from calpastatin mutant mice
    282. Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats
    283. Effects of selective excitotoxic prefrontal lesions on acquisition of nonmatching‐and matching‐to‐place in the T‐maze in the rat: Differential involvement of the …
    284. excitotoxic brain damage in the rat induces interleukin‐1β protein in microglia and astrocytes: Correlation with the progression of cell death
    285. Group I metabotropic glutamate receptors reduce excitotoxic injury and may facilitate neurogenesis
    286. Specific antagonism of excitotoxic action of ‘uncommon’amino acids assayed in organotypic mouse cortical cultures
    287. Hemoglobin potentiates excitotoxic injury in cortical cell culture
    288. Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury
    289. Selective excitotoxic pathology in the rat hippocampus
    290. excitotoxic septal lesions result in spatial memory deficits and altered flexibility of hippocampal single-unit representations
    291. excitotoxic calcium overload in a subpopulation of mitochondria triggers delayed death in hippocampal neurons
    292. BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge
    293. Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington’s disease
    294. Topiramate prevents excitotoxic damage in the newborn rodent brain
    295. Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and …
    296. Guanosine enhances glutamate uptake in brain cortical slices at normal and excitotoxic conditions
    297. Release of TNF alpha in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage.
    298. Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration
    299. δ-, but not μ-and κ-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury
    300. Dual-gene, dual-cell type therapy against an excitotoxic insult by bolstering neuroenergetics
    301. Transient expression of the NG2 proteoglycan by a subpopulation of activated macrophages in an excitotoxic hippocampal lesion
    302. excitotoxic and post-ischemic neurodegeneration: Involvement of transglutaminases
    303. Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death
    304. Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral …
    305. Ionized intracellular calcium concentration predicts excitotoxic neuronal death: observations with low-affinity fluorescent calcium indicators
    306. Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system
    307. excitotoxic lesions of the medial prefrontal cortex attenuate fear responses in the elevated-plus maze, social interaction and shock probe burying tests
    308. Perseveration and strategy in a novel spatial self-ordered sequencing task for nonhuman primates: effects of excitotoxic lesions and dopamine depletions of the …
    309. Vinpocetin protects against excitotoxic cell death in primary cultures of rat cerebral cortex
    310. Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington’s disease, as demonstrated by adenoviral gene …
    311. Quantitative analysis of the generation of different striatal neuronal subtypes in the adult brain following excitotoxic injury
    312. Behavioral and morphological alterations following neonatal excitotoxic lesions of the medial prefrontal cortex in rats
    313. excitotoxic neuronal damage and neuropsychiatric disorders
    314. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β‐peptide toxicity
    315. excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition
    316. Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats
    317. The effect of excitotoxic lesions centered on the hippocampus or perirhinal cortex in object recognition and spatial memory tasks.
    318. Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice
    319. excitotoxic lesions of the hippocampus disrupt runway but not consummatory contrast
    320. excitotoxic mechanisms in the pathogenesis of dementia
    321. Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate
    322. Specific neuronal protein: a new tool for histological evaluation of excitotoxic lesions
    323. Altered sexual partner preference in male ferrets given excitotoxic lesions of the preoptic area/anterior hypothalamus
    324. A primate model of Huntington’s disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon
    325. Mitochondrial uncoupling protein‐2 protects the immature brain from excitotoxic neuronal death
    326. Proton magnetic resonance spectroscopy in Huntington’s disease: Evidence in favour of the glutamate excitotoxic theory?
    327. Hypoxic and excitotoxic damage to cultured rat retinal ganglion cells
    328. excitotoxic acid lesions of the primate subthalamic nucleus result in transient dyskinesias of the contralateral limbs
    329. Differential oxidative stress in oligodendrocytes and neurons after excitotoxic insults and protection by natural polyphenols
    330. Caspase-mediated degradation of AMPA receptor subunits: a mechanism for preventing excitotoxic necrosis and ensuring apoptosis
    331. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures
    332. A specific form of cognitive rigidity following excitotoxic lesions of the basal forebrain in marmosets
    333. Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease
    334. Cholinergic system and memory in the rat: effects of chronic ethanol, embryonic basal forebrain brain transplants and excitotoxic lesions of cholinergic basal forebrain …
    335. excitotoxic cytopathology, progression, and reversibility of thiamine deficiency-induced diencephalic lesions
    336. excitotoxic mitochondrial depolarisation requires both calcium and nitric oxide in rat hippocampal neurons
    337. excitotoxic degeneration is initiated at non-random sites in cultured rat cerebellar neurons
    338. excitotoxic cell death dependent on inhibitory receptor activation
    339. … a reactive oxygen species (ROS)-dependent fashion and can operate as a ROS scavenger and as a respiratory substrate in cerebellar neurons undergoing excitotoxic …
    340. Domoic acid: a dementia-inducing excitotoxic food poison with kainic acid receptor specificity
    341. Apoptosis in substantia nigra following developmental striatal excitotoxic injury
    342. Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice
    343. Wogonin inhibits excitotoxic and oxidative neuronal damage in primary cultured rat cortical cells
    344. Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage
    345. Effects of excitotoxic lesions of the basolateral amygdala on cocaine-seeking behavior and cocaine conditioned place preference in rats
    346. Müller cell swelling, glutamate uptake, and excitotoxic neurodegeneration in the isolated rat retina
    347. Reactive astrocytosis from excitotoxic injury in hippocampal organ culture parallels that seen in vivo
    348. Changes in the diffusion of water and intracellular metabolites after excitotoxic injury and global ischemia in neonatal rat brain
    349. Enhanced drinking after excitotoxic lesions of the parabrachial nucleus in the rat
    350. Glucocorticoids, stress and exacerbation of excitotoxic neuron death
    351. excitotoxic versus apoptotic mechanisms of neuronal cell death in perinatal hypoxia/ischemia
    352. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage
    353. Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration
    354. Endogenous BDNF protein is increased in adult rat hippocampus after a kainic acid induced excitotoxic insult but exogenous BDNF is not neuroprotective
    355. excitotoxic amino acid injections into the medial amygdala facilitate maternal behavior in virgin female rats
    356. excitotoxic lesions of the rat medial prefrontal cortex: effects on abnormal behaviors associated with neonatal hippocampal damage
    357. Dependence of excitotoxic neurodegeneration on mitochondrial aconitase inactivation
    358. Rolipram reduces excitotoxic neuronal damage
    359. Evidence for glutamate-mediated excitotoxic mechanisms during photoreceptor degeneration in the rd1 mouse retina
    360. Differential effects of excitotoxic lesions of the amygdala on cocaine-induced conditioned locomotion and conditioned place preference
    361. Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophrenia
    362. Time course of glial proliferation and glial apoptosis following excitotoxic CNS injury
    363. The hippocampus and appetitive Pavlovian conditioning: effects of excitotoxic hippocampal lesions on conditioned locomotor activity and autoshaping
    364. Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage
    365. Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury
    366. Calpain activation contributes to dendritic remodeling after brief excitotoxic injury in vitro
    367. Effects of excitotoxic lesions in the ventral striatopallidal–thalamocortical pathway on odor reversal learning: inability to extinguish an incorrect response
    368. Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis
    369. Nitric oxide and S‐nitrosylation: excitotoxic and cell signaling mechanism
    370. Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors
    371. excitotoxic injury to mitochondria isolated from cultured neurons
    372. Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate
    373. Proinflammatory cytokines and interleukin‐9 exacerbate excitotoxic lesions of the newborn murine neopallium
    374. Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor
    375. Novel concepts in excitotoxic neurodegeneration after stroke
    376. Testosterone amplifies excitotoxic damage of cultured oligodendrocytes
    377. Differential blood–brain barrier breakdown and leucocyte recruitment following excitotoxic lesions in juvenile and adult rats
    378. Induction of GABAergic phenotype in a neural stem cell line for transplantation in an excitotoxic model of Huntington’s disease
    379. Neuronal death and blood–brain barrier breakdown after excitotoxic injury are independent processes
    380. Comparative behavioral changes between male and female postpubertal rats following neonatal excitotoxic lesions of the ventral hippocampus
    381. Endogenous methylarginines regulate neuronal nitric-oxide synthase and prevent excitotoxic injury
    382. Enhanced nucleus accumbens dopamine and plasma corticosterone stress responses in adult rats with neonatal excitotoxic lesions to the medial prefrontal cortex
    383. 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures
    384. Low-dose ouabain protects against excitotoxic apoptosis and up-regulates nuclear Bcl-2 in vivo
    385. excitotoxic lesions of the core and shell subregions of the nucleus accumbens differentially disrupt body weight regulation and motor activity in rat
    386. The nature and timing of excitotoxic neuronal necrosis in the cerebral cortex, hippocampus and thalamus due to flurothyl-induced status epilepticus
    387. Selective activation of central subtypes of the nicotinic acetylcholine receptor has opposite effects on neonatal excitotoxic brain injuries
    388. Inhibition of free radical production or free radical scavenging protects from the excitotoxic cell death mediated by glutamate in cultures of cerebellar granule neurons
    389. excitotoxic food additives: functional teratological aspects
    390. N‐methyl‐D‐aspartate receptor‐mediated mitochondrial Ca2+ overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after …
    391. Transcription of the NR1 subunit of the N-methyl-D-aspartate receptor is down-regulated by excitotoxic stimulation and cerebral ischemia
    392. Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions.
    393. Antioxidant treatment protects striatal neurons against excitotoxic insults
    394. Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death
    395. excitotoxic destruction facilitates brain tumor growth
    396. Nervous system-specific expression of a novel serine protease: regulation in the adult rat spinal cord by excitotoxic injury
    397. Growth factors protect neurons against excitotoxic/ischemic damage by stabilizing calcium homeostasis.
    398. Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I
    399. Antagonists for group I mGluRs attenuate excitotoxic neuronal death in cortical cultures
    400. excitotoxic lesions of the parabrachial nuclei prevent conditioned taste aversions and sodium appetite in rats.
    401. Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal …
    402. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington’s …
    403. excitotoxic cell death
    404. Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain
    405. The effects of excitotoxic lesions of the nucleus accumbens core or shell regions on intravenous heroin self-administration in rats
    406. BDNF heightens the sensitivity of motor neurons to excitotoxic insults through activation of TrkB
    407. Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death
    408. The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and …
    409. excitotoxic mechanism of cell swelling in rat cerebral cortical slices treated acutely with ammonia
    410. excitotoxic neuronal injury in chronic homocysteine neurotoxicity studied in vitro: the role of NMDA and group I metabotropic glutamate receptors
    411. Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo
    412. High-affinity calcium indicators underestimate increases in intracellular calcium concentrations associated with excitotoxic glutamate stimulations
    413. Dimethyl sulfoxide suppresses NMDA-and AMPA-induced ion currents and calcium influx and protects against excitotoxic death in hippocampal neurons
    414. S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: clinical implications for the role of S100B in excitotoxic brain injury
    415. Learning disturbances following excitotoxic lesion of cholinergic pedunculo-pontine nucleus in the rat
    416. Calretinin and calbindin D-28k delay the onset of cell death after excitotoxic stimulation in transfected P19 cells
    417. The critical role of calpain versus caspase activation in excitotoxic injury induced by nitric oxide
    418. Mitochondrial peroxiredoxin‐3 protects hippocampal neurons from excitotoxic injury in vivo
    419. Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo
    420. Dissociation of function within the hippocampus: effects of dorsal, ventral and complete excitotoxic hippocampal lesions on spatial navigation
    421. excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington’s disease in rats: protective role of iron porphyrinate 5, 10, 15, 20-tetrakis (4 …
    422. excitotoxic mechanisms may be involved in the pathophysiology of tardive dyskinesia.
    423. Tf-lipoplex-mediated NGF gene transfer to the CNS: neuronal protection and recovery in an excitotoxic model of brain injury
    424. Endocannabinoids potently protect the newborn brain against AMPA‐kainate receptor‐mediated excitotoxic damage
    425. Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice
    426. Oral treatment with rofecoxib reduces hippocampal excitotoxic neurodegeneration
    427. excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding
    428. … minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of …
    429. Interleukin‐1β and the interleukin‐1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat
    430. Barbiturates induce mitochondrial depolarization and potentiate excitotoxic neuronal death
    431. Neural cell adhesion molecule L1-transfected embryonic stem cells promote functional recovery after excitotoxic lesion of the mouse striatum
    432. The effect of excitotoxic hippocampal lesions on simple and conditional discrimination learning in the rat
    433. Activation of the ERK1/2 signaling cascade by excitotoxic spinal cord injury
    434. Anti-excitotoxic actions of taurine in the rat hippocampus studied in vivo and in vitro
    435. excitotoxic neurodegeneration induced by intranasal administration of kainic acid in C57BL/6 mice
    436. Selected peptides targeted to the NMDA receptor channel protect neurons from excitotoxic death
    437. The effects of excitotoxic lesions of the basal forebrain on the acquisition, retention and serial reversal of visual discriminations in marmosets
    438. Nitric oxide mediates excitotoxic and anoxic damage in rat retinal ganglion cells cocultured with astroglia
    439. Delayed excitotoxic neurodegeneration induced by excitatory amino acid agonists in isolated retina
    440. The effect of streptozotocin-induced diabetes on the release of excitotoxic and other amino acids from the ischemic rat cerebral cortex
    441. Impaired delayed spatial win-shift behaviour on the eight arm radial maze following excitotoxic lesions of the medial prefrontal cortex in the rat
    442. … factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 …
    443. Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA-and ibotenic acid-induced excitotoxic lesions of the basal …
    444. Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo
    445. Enhancement of amphetamine-induced locomotor activity and dopamine release in nucleus accumbens following excitotoxic lesions of the hippocampus
    446. excitotoxic amino acids
    447. excitotoxic activation of the NMDA receptor results in inhibition of calcium/calmodulin kinase II activity in cultured hippocampal neurons
    448. Imaging of primary and remote ischaemic and excitotoxic brain lesions. An autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat
    449. The identification and characterization of excitotoxic nerve-endings in Alzheimer disease
    450. excitotoxic model of post-traumatic syringomyelia in the rat
    451. Evidence for proteolytic cleavage of brevican by the ADAMTSs in the dentate gyrus after excitotoxic lesion of the mouse entorhinal cortex
    452. Neonatal hypoxic-ischemic or excitotoxic striatal injury results in a decreased adult number of substantia nigra neurons
    453. The effects of excitotoxic lesions of the nucleus accumbens on a matching to position task
    454. Effects of excitotoxic lesions of the basal forebrain on MFB self-stimulation
    455. excitotoxic model of post-traumatic syringomyelia in the rat
    456. The excitotoxic concept
    457. excitotoxic death of a subset of embryonic rat motor neurons in vitro
    458. Cu/Zn superoxide dismutase expression in the postnatal rat brain following an excitotoxic injury
    459. Apoptosis and necrosis occurring in excitotoxic cell death in isolated chick embryo retina
    460. Acute excitotoxic injury induces expression of monocyte chemoattractant protein-1 and its receptor, CCR2, in neonatal rat brain
    461. Implication of NMDA type glutamate receptors in neural regeneration and neoformation of synapses after excitotoxic injury in the guinea pig cochlea
    462. Lentiviral‐mediated gene transfer of brain‐derived neurotrophic factor is neuroprotective in a mouse model of neonatal excitotoxic challenge
    463. The anti-excitotoxic effects of certain anesthetics, analgesics and sedative-hypnotics
    464. p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults
    465. The CNS acute inflammatory response to excitotoxic neuronal cell death
    466. Effects of excitotoxic lesions of the rat ventral striatum on the perception of reward cost
    467. Ultrastructure of excitotoxic neuronal death in murine cortical culture
    468. Loss of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus: rescue by neurotrophins
    469. Inhibition by anion channel blockers of ischemia-evoked release of excitotoxic and other amino acids from rat cerebral cortex
    470. Selective excitotoxic lesions of the hippocampus and basolateral amygdala have dissociable effects on appetitive cue and place conditioning based on path …
    471. Astrocytic factors protect neuronal integrity and reduce microglial activation in an in vitro model of N‐methyl‐d‐aspartate‐induced excitotoxic injury in organotypic …
    472. Inhibition of excitotoxic neuronal death by methanol extract of Acori graminei rhizoma in cultured rat cortical neurons
    473. Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging
    474. excitotoxic lesions of the pre‐and parasubiculum disrupt the place fields of hippocampal pyramidal cells
    475. Neuronal protein kinase signaling cascades and excitotoxic cell death
    476. Selective vulnerability of the CA1 region of hippocampus to the indirect excitotoxic effects of malonic acid
    477. The effects of endogenous interleukin-10 on gray matter damage and the development of pain behaviors following excitotoxic spinal cord injury in the mouse
    478. Activated microglial cells migrate towards sites of excitotoxic neuronal injury inside organotypic hippocampal slice cultures
    479. AMPA receptors are the major mediators of excitotoxic death in mature oligodendrocytes
    480. Topiramate reduces excitotoxic and ischemic injury in the rat retina
    481. Effects of excitotoxic lesions of the central amygdaloid nucleus on the potentiation of reward-related stimuli by intra-accumbens amphetamine
    482. Thalamic amnesia reconsidered: excitotoxic lesions of the intralaminar nuclei, but not the mediodorsal nucleus, disrupt place delayed matching-to-sample …
    483. Extragonadal synthesis of estradiol is protective against kainic acid excitotoxic damage to the hippocampus
    484. Platelet-derived growth factor-BB pretreatment attenuates excitotoxic death in cultured hippocampal neurons
    485. Neurons are protected from excitotoxic death by p53 antisense oligonucleotides delivered in anionic liposomes
    486. Gas1 is induced during and participates in excitotoxic neuronal death
    487. Potent protection of ferulic acid against excitotoxic effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing …
    488. excitotoxic death induced by released glutamate in depolarized primary cultures of mouse cerebellar granule cells is dependent on GABAA receptors and niflumic …
    489. The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo
    490. Effects of excitotoxic lesions of the basolateral amygdala on conditional discrimination learning with primary and conditioned reinforcement
    491. NMDA and non-NMDA receptor antagonists protect against excitotoxic injury in the rat spinal cord
    492. Dopaminergic neurotoxins require excitotoxic stimulation in organotypic cultures
    493. Calcium buffering and protection from excitotoxic cell death by exogenous calbindin-D28k in HEK 293 cells
    494. Comparative effects of excitotoxic lesions of the hippocampus and septum/diagonal band on conditional visual discrimination and spatial learning
    495. Disruption of Pavlovian contextual conditioning by excitotoxic lesions of the nucleus accumbens core.
    496. Microglial expression of prostaglandin EP3 receptor in excitotoxic lesions in the rat striatum
    497. Aminooxyacetic acid produces excitotoxic lesions in the rat striatum
    498. The influence of excitotoxic basal ganglia lesions on motor performance in the common marmoset
    499. excitotoxic lesions centered on perirhinal cortex produce delay-dependent deficits in a test of spatial memory.
    500. Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice
    501. Mice transgenically overexpressing sulfonylurea receptor 1 in forebrain resist seizure induction and excitotoxic neuron death
    502. excitotoxic cell death and delayed rescue in human neurons derived from NT2 cells
    503. Contribution of endogenous glycine site NMDA agonists to excitotoxic retinal damage in vivo
    504. The role of excitotoxic injury in post-traumatic syringomyelia
    505. Diffusion-weighted MR imaging in a rat model of syringomyelia after excitotoxic spinal cord injury
    506. Changes in sleep–waking cycle after striatal excitotoxic lesions
    507. Iodoacetate produces striatal excitotoxic lesions
    508. Protection provided by cyclosporin A against excitotoxic neuronal death is genotype dependent
    509. Up-regulation of Eph tyrosine kinase receptors after excitotoxic injury in adult hippocampus
    510. excitotoxic lesions of the septum produce anxiolytic effects in the elevated plus-maze and the shock-probe burying tests
    511. GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults
    512. Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum
    513. … and dysfunctions of the nucleus basalis as Alzheimer’s disease models: general and critical overview and analysis of the long-term changes in several excitotoxic …
    514. Selective excitotoxic lesions of the nucleus accumbens core and shell differentially affect aversive Pavlovian conditioning to discrete and contextual cues
    515. Protective effects of PACAP in excitotoxic striatal lesion
    516. Heparin-binding epidermal growth factor-like growth factor in hippocampus: modulation of expression by seizures and anti-excitotoxic action
    517. Platelet‐activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and …
    518. Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca2+ concentration
    519. excitotoxic-amino-acids.pdf”>excitotoxic amino acids: research applications and safety implications
    520. Chronic, selective forebrain responses to excitotoxic dorsal horn injury
    521. excitotoxic neuronal injury in acute homocysteine neurotoxicity: role of calcium and mitochondrial alterations
    522. excitotoxic brain injury stimulates expression of the chemokine receptor CCR5 in neonatal rats
    523. The effect of excitotoxic lesions centered on the perirhinal cortex in two versions of the radial arm maze task.
    524. Contingent versus incidental context processing during conditioning: dissociation after excitotoxic hippocampal plus dentate gyrus lesions
    525. Tumor necrosis factor α increases neuronal vulnerability to excitotoxic necrosis by inducing expression of the AMPA–glutamate receptor subunit GluR1 via an acid …
    526. GABA accelerates excitotoxic cell death in cortical cultures: protection by blockers of GABA-gated chloride channels
    527. excitotoxic damage in traumatic brain injury
    528. Multiple pathways of neuroprotection against oxidative stress and excitotoxic injury in immature primary hippocampal neurons
    529. Naproxen reduces excitotoxic neurodegeneration in vivo with an extended therapeutic window
    530. Effects of laterodorsal tegmentum excitotoxic lesions on behavioral and dopamine responses evoked by morphine and d-amphetamine
    531. Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre‐ and postsynaptic sites in the rat striatum
    532. Comparative behavioral changes in postpubertal rats after neonatal excitotoxic lesions of the ventral hippocampus and the prefrontal cortex
    533. Interpretation of intrinsic optical signals and calcein fluorescence during acute excitotoxic insult in the hippocampal slice
    534. excitotoxic lesions of the pre-and parasubiculum disrupt object recognition and spatial memory processes.
    535. excitotoxic neurodegeneration induced by deprivation of oxygen and glucose in isolated retina.
    536. Calpain I activation in rat hippocampal neurons in culture is NMDA receptor selective and not essential for excitotoxic cell death
    537. Ca2+-independent excitotoxic neurodegeneration in isolated retina, an intact neural net: a role for Cl− and inhibitory transmitters
    538. Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol
    539. Both electrolytic and excitotoxic lesions of nucleus accumbens disrupt latent inhibition of learning in rats
    540. Striatal modulation of cAMP‐response‐element‐binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington’s disease
    541. Monocyte chemoattractant protein-1 is a mediator of acute excitotoxic injury in neonatal rat brain
    542. Brain‐derived neurotrophic factor induces excitotoxic sensitivity in cultured embryonic rat spinal motor neurons through activation of the phosphatidylinositol 3‐kinase …
    543. Convection-enhanced selective excitotoxic ablation of the neurons of the globus pallidus internus for treatment of parkinsonism in nonhuman primates
    544. Differential effects of excitotoxic basolateral and corticomedial lesions of the amygdala on the behavioural and endocrine responses to either sexual or aggression …
    545. excitotoxic lesions of the hippocampus leave sensory preconditioning intact: Implications for models of hippocampal functioning.
    546. Opposite effects of TGF-β1 on rapidly-and slowly-triggered excitotoxic injury
    547. Primary CA1 and conditionally immortal MHP36 cell grafts restore conditional discrimination learning and recall in marmosets after excitotoxic lesions of the …
    548. Developmental spectrum of the excitotoxic cascade induced by ibotenate: a model of hypoxic insults in fetuses and neonates
    549. Increase in ferric and ferrous iron in the rat hippocampus with time after kainate-induced excitotoxic injury
    550. Intrinsic neurons of fastigial nucleus mediate neurogenic neuroprotection against excitotoxic and ischemic neuronal injury in rat
    551. Discriminable excitotoxic effects of ibotenic acid, AMPA, NMDA and quinolinic acid in the rat laterodorsal tegmental nucleus
    552. Transplanted human embryonic germ cell‐derived neural stem cells replace neurons and oligodendrocytes in the forebrain of neonatal mice with excitotoxic brain …
    553. Effects of excitotoxic brain lesions on taste-mediated odor learning in the rat
    554. excitotoxic lesions of the pedunculopontine tegmental nucleus of the rat. II. Examination of eating and drinking, rotation, and reaching and grasping following …
    555. Changes in secondary glutamate release underlie the developmental regulation of excitotoxic neuronal cell death
    556. Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system—II. Cholinergic drugs …
    557. Mechanistic distinctions between excitotoxic and acidotic hippocampal damage in an in vitro model of ischemia
    558. Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons
    559. excitotoxic lesion of rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53-inducible genes Bax and Gadd-45 in brain areas …
    560. BDNF, and full length and truncated TrkB expression in the hippocampus of the rat following kainic acid excitotoxic damage. Evidence of complex time-dependent and …
    561. Gustatory functions, sodium appetite, and conditioned taste aversion survive excitotoxic lesions of the thalamic taste area.
    562. Conditions affecting the onset, severity, and progression of a spontaneous pain-like behavior after excitotoxic spinal cord injury
    563. Hypoxia induces an excitotoxic-type of dark cell degeneration in cerebellar Purkinje neurons
    564. Evaluation of the pathologic characteristics of excitotoxic spinal cord injury with MR imaging
    565. 2‐deoxy‐d‐glucose protects hippocampal neurons against excitotoxic and oxidative injury: Evidence for the involvement of stress proteins
    566. excitotoxic mechanisms in hypoglycaemic hippocampal injury
    567. The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury
    568. Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage
    569. excitotoxic lesions of the pedunculopontine tegmental nucleus in rats impair performance on a test of sustained attention
    570. The effects of excitotoxic lesions of the basolateral amygdala on the acquisition of heroin-seeking behaviour in rats
    571. The effects of excitotoxic lesions of the substantia innominata, ventral and dorsal globus pallidus on the acquisition and retention of a conditional visual discrimination …
    572. Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra
    573. excitotoxic food additives–relevance of animal studies to human safety.
    574. Interleukin‐1β exacerbates and interleukin‐1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic …
    575. Chronic multichannel recordings from organotypic hippocampal slice cultures: protection from excitotoxic effects of NMDA by non-competitive NMDA antagonists
    576. Fenamates protect neurons against ischemic and excitotoxic injury in chick embryo retina
    577. Rapid appearance of β-amyloid precursor protein immunoreactivity in glial cells follwing excitotoxic brain injury
    578. Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions
    579. Are human neurodegenerative disorders linked to environmental chemicals with excitotoxic properties?
    580. Glutamate-mediated excitotoxic death of cultured striatal neurons is mediated by non-NMDA receptors
    581. Adrenocorticosteroid receptor blockade and excitotoxic challenge regulate adrenocorticosteroid receptor mRNA levels in hippocampus
    582. excitotoxic and metabolic damage to the rodent striatum: role of the P75 neurotrophin receptor and glial progenitors
    583. Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate
    584. excitotoxic preconditioning elicited by both glutamate and hypoxia and abolished by lactate transport inhibition in rat hippocampal slices
    585. Late N‐methyl‐d‐aspartate receptor blockade rescues hippocampal neurons from excitotoxic stress and death after 4‐aminopyridine‐induced epilepsy
    586. SIN‐1‐induced cytotoxicity in mixed cortical cell culture: peroxynitrite‐dependent and‐independent induction of excitotoxic cell death
    587. Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury?
    588. … that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/plasmin protease cascade during excitotoxic injury
    589. excitotoxic hippocampal injury is attenuated in thioredoxin transgenic mice
    590. Intrinsic optical signaling denoting neuronal damage in response to acute excitotoxic insult by domoic acid in the hippocampal slice
    591. Bright light suppresses hyperactivity induced by excitotoxic dorsal hippocampus lesions in the rat.
    592. Vulnerability to excitotoxic stimuli of cultured rat hippocampal neurons containing the calcium-binding proteins calretinin and calbindin D28K
    593. Comparative effects of levobupivacaine and racemic bupivacaine on excitotoxic neuronal death in culture and N-methyl-D-aspartate-induced seizures in mice
    594. excitotoxic injury stimulates pro-drug-induced 7-chlorokynurenate formation in the rat striatum in vivo
    595. Methylmalonic acid induces excitotoxic neuronal damage in vitro
    596. Increased amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: neuroprotection by …
    597. excitotoxic hippocampal lesions disrupt allocentric spatial learning in mice: effects of strain and task demands
    598. Nitric oxide participates in excitotoxic mechanisms induced by chemical hypoxia
    599. Decrease of proinflammatory molecules correlates with neuroprotective effect of the fluorinated salicylate triflusal after postnatal excitotoxic damage
    600. Triflusal posttreatment inhibits glial nuclear factor-κB, downregulates the glial response, and is neuroprotective in an excitotoxic injury model in postnatal brain
    601. Amelioration of behavioral deficits in a rat model of Huntington’s disease by an excitotoxic lesion to the globus pallidus
    602. Neuronal expression of AP-1 proteins in excitotoxic-neurodegenerative disorders and following nerve fiber lesions
    603. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice
    604. Inhibition of cell cycle pathway by flavopiridol promotes survival of cerebellar granule cells after an excitotoxic treatment
    605. excitotoxic mechanisms of neurodegeneration in transmissible spongiform encephalopathies.
    606. Effects of agmatine, interleukin-10, and cyclosporin on spontaneous pain behavior after excitotoxic spinal cord injury in rats
    607. excitotoxic lesions of the gustatory thalamus eliminate consummatory but not instrumental successive negative contrast in rats
    608. excitotoxic degeneration of hypothalamic orexin neurons in slice culture
    609. Prevention of post-traumatic excitotoxic brain damage with NMDA antagonist drugs: a new strategy for the nineties
    610. Prostaglandin A1 protects striatal neurons against excitotoxic injury in rat striatum
    611. Contrasting effects of excitotoxic lesions of the prefrontal cortex on the behavioural response to D-amphetamine and presynaptic and postsynaptic measures of striatal …
    612. Spatial discrimination deficits by excitotoxic lesions in the Morris water escape task
    613. Prostate apoptosis response‐4 production in synaptic compartments following apoptotic and excitotoxic insults: evidence for a pivotal role in mitochondrial dysfunction …
    614. Quantitative analysis of microglial reaction to a cortical excitotoxic lesion in the early postnatal brain
    615. Glial expression of small heat shock proteins following an excitotoxic lesion in the immature rat brain
    616. Neuroprotection from NMDA excitotoxic lesion by Cu/Zn superoxide dismutase gene delivery to the postnatal rat brain by a modular protein vector
    617. Distinct roles for striatal subregions in mediating response processing revealed by focal excitotoxic lesions.
    618. Neurons derived from embryonic stem (ES) cells resemble normal neurons in their vulnerability to excitotoxic death
    619. Differential brain area vulnerability to long-term subcortical excitotoxic lesions
    620. Cortical neurons containing somatostatin‐or parvalbumin‐like immunoreactivity are atypically vulnerable to excitotoxic injury in vitro
    621. excitotoxic insults to the optic nerve alter visual evoked potentials
    622. The immunosuppressant mycophenolate mofetil attenuates neuronal damage after excitotoxic injury in hippocampal slice cultures
    623. Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death
    624. Effects of excitotoxic amino acids on pituitary hormone secretion in the rat
    625. Susceptibilities to and mechanisms of excitotoxic cell death of adult mouse inner retinal neurons in dissociated culture
    626. Effects of adrenal medullary transplants on pain-related behaviors following excitotoxic spinal cord injury
    627. Apoptotic neuron death in rat substantia nigra induced by striatal excitotoxic injury is developmentally dependent
    628. (-)-Nicotine protects against systemic kainic acid-induced excitotoxic effects
    629. excitotoxic insult due to ibogaine leads to delayed induction of neuronal NOS in Purkinje cells.
    630. The severity of excitotoxic brain injury is dependent on brain temperature in immature rat
    631. Long-term evolution of excitotoxic cortical dysgenesis induced in the developing rat brain
    632. Rapid subcellular redistribution of Bax precedes caspase-3 and endonuclease activation during excitotoxic neuronal apoptosis in rat brain
    633. Chronic excitotoxic lesion of the dorsal raphe nucleus induces sodium appetite
    634. excitotoxic damage in neurotrauma: fact or fiction
    635. 17β-Estradiol enhances cortical cholinergic innervation and preserves synaptic density following excitotoxic lesions to the rat nucleus basalis magnocellularis
    636. Inhibition of TNF-α can attenuate or exacerbate excitotoxic injury in neonatal rat brain
    637. Early appearance of functional deficits after neonatal excitotoxic and hypoxic-ischemic injury: fragile recovery after development and role of the NMDA receptor
    638. Aminoglutethimide prevents excitotoxic and ischemic injuries in cortical neurons
    639. Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury
    640. excitotoxic lesions of the rat entorhinal cortex. Effects of selective neuronal damage on acquisition and retention of a non-spatial reference memory task
    641. excitotoxic effect of kainic acid on chicken otoacoustic emissions and cochlear potentials
    642. excitotoxic lesions of the tegmental pedunculopontine nucleus impair copulation in naive male rats and block the rewarding effects of copulation in experienced male …
    643. excitotoxic effects of non-NMDA receptor agonists in organotypic corticostriatal slice cultures
    644. Calpain inhibitors prevent nitric oxide-triggered excitotoxic apoptosis
    645. VIP neuroprotection against excitotoxic lesions of the developing mouse brain
    646. Diltiazem protects against neurotoxicity induced by excitotoxic amino acids on cochlear afferent fibers
    647. N-methyl-D-aspartate receptor subunit expression and phosphorylation following excitotoxic spinal cord injury in rats
    648. excitotoxic lesions of the medial amygdala differentially disrupt prolactin secretory responses in cycling and mated female rats
    649. Role of zinc in blockade of excitotoxic action of quinolinic acid by picolinic acid
    650. excitotoxic swelling occurs in oxygen and glucose deprived human cortical slices
    651. Mitochondrial transmembrane potential and free radical production in excitotoxic neurodegeneration
    652. Effects of excitotoxic thalamic intralaminar nuclei lesions on attention and working memory
    653. The effects of excitotoxic lesions of the pedunculopontine tegmental nucleus on conditioned place preference to 4%, 12% and 20% sucrose solutions
    654. Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism
    655. Potentiation of excitotoxic injury by high concentrations of extracellular reduced glutathione
    656. NOS Expression in Nigral Cells after excitotoxic and Non‐excitotoxic Lesion of the Pedunculopontine Tegmental Nucleus
    657. Is the cuneiform nucleus a critical component of the mesencephalic locomotor region? An examination of the effects of excitotoxic lesions of the cuneiform nucleus on …
    658. gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats
    659. Effects of excitotoxic lesions of the central or basolateral nucleus of the amygdala on naloxone-precipitated withdrawal-induced conditioned place aversion in …
    660. excitotoxic lateral pallidotomy does not relieve L-DOPA-induced dyskinesia in MPTP parkinsonian monkeys
    661. Opioid peptide messenger RNA expression is increased at spinal and supraspinal levels following excitotoxic spinal cord injury
    662. The vulnerability of spinal cord neurons to excitotoxic injury: comparison with cortical neurons
    663. Galantamine-induced behavioral recovery after sublethal excitotoxic lesions to the rat medial septum
    664. Early evolution and recovery from excitotoxic injury in the neonatal rat brain: a study combining magnetic resonance imaging, electrical impedance, and histology
    665. Role of the excitotoxic mechanism in the development of neuronal damage following repeated brief cerebral ischemia in the gerbil: protective effects of MK-801 and …
    666. Immediate early gene activation during the initial phases of the excitotoxic cascade
    667. Transneuronal degeneration in substantia nigra pars reticulata following striatal excitotoxic injury in adult rat: time-course, distribution and morphology of cell death
    668. Thioltransferase (glutaredoxin) mediates recovery of motor neurons from excitotoxic mitochondrial injury
    669. excitotoxic hippocampal membrane breakdown and its inhibition by bilobalide: role of chloride fluxes
    670. excitotoxic lesions of the pedunculopontine differentially mediate morphine-and d-amphetamine-evoked striatal dopamine efflux and behaviors
    671. Seizures and selective CA-1 hippocampal lesions induced by an excitotoxic cyanide metabolite, 2-iminothiazolidine-4-carboxylic acid.
    672. Cerebral organic acid disorders induce neuronal damage via excitotoxic organic acids in vitro
    673. The cardiac glycoside ouabain potentiates excitotoxic injury of adult neurons in rat hippocampus
    674. Lack of excitotoxic cell death in serum-free cultures of rat cerebral cortex
    675. An examination of the effects of bilateral excitotoxic lesions of the pedunculopontine tegmental nucleus on responding to sucrose reward
    676. excitotoxic lesions of the pedunculopontine tegmental nucleus of the rat. I. Comparison of the effects of various excitotoxins, with particular reference to the loss of …
    677. Hippocampal neurons exhibit both persistent Ca2+ influx and impairment of Ca2+ sequestration/extrusion mechanisms following excitotoxic glutamate exposure
    678. 1‐Methyl‐4‐phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism
    679. Ectopic parvalbumin expression in mouse forebrain neurons increases excitotoxic injury provoked by ibotenic acid injection into the striatum
    680. Effects of neonatal excitotoxic lesions of the entorhinal cortex on cognitive functions in the adult rat
    681. The neuroprotective effects of the recombinant interleukin–1 receptor antagonist rhIL–1ra after excitotoxic stimulation with kainic acid and its relationship to the …
    682. Systemic application of granulocyte-colony stimulating factor and stem cell factor exacerbates excitotoxic brain injury in newborn mice
    683. excitotoxic lesions of the parafascicular nucleus produce deficits in a socially transmitted food preference
    684. Protective action of idebenone against excitotoxic degeneration in cultured cortical neurons
    685. Interactive effects of excitotoxic injury and dietary restriction on microgliosis and neurogenesis in the hippocampus of adult mice
    686. excitotoxic lesions of the mediodorsal thalamic nucleus attenuate intravenous cocaine self-administration
    687. excitotoxic injury induces monocyte chemoattractant protein-1 expression in neonatal rat brain
    688. Deficits in response initiation, but not attention, following excitotoxic lesions of posterior parietal cortex in the rat
    689. Biphasic NF-κB activation in the excitotoxic hippocampus
    690. Timing the excitotoxic induction of heat shock protein 70 transcription.
    691. Gene therapies that enhance hippocampal neuron survival after an excitotoxic insult are not equivalent in their ability to maintain synaptic transmission
    692. Ischemia does not induce the release of excitotoxic amino acids from the hippocampus of newborn rats
    693. Glutamate receptor transmission and ischemic nerve cell damage: evidence for involvement of excitotoxic mechanisms
    694. Two temporal stages of oligodendroglial response to excitotoxic lesion in the gray matter of the adult rat brain
    695. Susceptibility of striatal neurons to excitotoxic injury correlates with basal levels of Bcl-2 and the induction of P53 and c-Myc immunoreactivity
    696. A comparison of excitotoxic lesions of the basal forebrain by kainate, quinolinate, ibotenate, N‐methyl‐d‐aspartate or quisqualate, and the effects on toxicity of 2 …
    697. excitotoxic basolateral amygdala lesions potentiate the memory impairment effect of muscimol injected into the medial septal area
    698. excitotoxic lesions of rat basal forebrain: differential effects on choline acetyltransferase in the cortex and amygdala
    699. Opposing effects of excitatory amino acids on chick embryo spinal cord motoneurons: excitotoxic degeneration or prevention of programmed cell death
    700. Are aminoglycoside antibiotics excitotoxic?
    701. Tat, a human immunodeficiency virus-1 derived protein, augments excitotoxic hippocampal injury in neonatal rats
    702. Proteasome inhibitors prevent cytochrome c release during apoptosis but not in excitotoxic death of cerebellar granule neurons
    703. Caspase-3-associated apoptotic cell death in excitotoxic necrosis of the entorhinal cortex following intraperitoneal injection of kainic acid in the rat
    704. In vivo role of caspases in excitotoxic neuronal death: generation and analysis of transgenic mice expressing baculoviral caspase inhibitor, p35, in postnatal neurons
    705. Inhibition of apoptosis‐inducing factor translocation is involved in protective effects of hepatocyte growth factor against excitotoxic cell death in cultured hippocampal …
    706. Cells over-expressing EAAT2 protect motoneurons from excitotoxic death in vitro
    707. Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical …
    708. … and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury
    709. Differential effects of prolonged high frequency stimulation and of excitotoxic lesion of the subthalamic nucleus on dopamine denervation‐induced cellular defects in …
    710. Dietary N-3 fatty acids inhibit ischaemic and excitotoxic brain damage in the rat
    711. Expression of inducible nitric oxide synthase and cyclooxygenase‐2 after excitotoxic damage to the immature rat brain
    712. β‐cyano‐L‐alanine toxicity: Evidence for the involvement of an excitotoxic mechanism
    713. Delayed death of septal cholinergic neurons after excitotoxic ablation of hippocampal neurons during early postnatal development in the rat
    714. Expression of growth inhibitory factor (metallothionein-III) mRNA and protein following excitotoxic immature brain injury
    715. Ciliary neurotrophic factor protects hippocampal neurons from excitotoxic damage
    716. Reversed actrocytic GLT-1 during ischemia is crucial to excitotoxic death of neurons, but contributes to the survival of astrocytes themselves
    717. Stat3 and NFκB glial expression after excitotoxic damage to the postnatal brain
    718. iNOS contribution to the NMDA-induced excitotoxic lesion in the rat striatum
    719. Intracellular glutathione levels determine cerebellar granule neuron sensitivity to excitotoxic injury by kainic acid
    720. Stability of septohippocampal neurons following excitotoxic lesions of the rat hippocampus
    721. Effects of excitotoxic lesions of the septum and vertical limb nucleus of the diagonal band of Broca on conditional visual discrimination: relationship between …
    722. Quisqualate‐induced excitotoxic death of glial cells: Transient vulnerability of cultured astrocytes
    723. Choline release and inhibition of phosphatidylcholine synthesis precede excitotoxic neuronal death but not neurotoxicity induced by serum deprivation
    724. Kainic acid-induced excitotoxic hippocampal neurodegeneration in C57BL/6 mice: B cell and T cell subsets may contribute differently to the pathogenesis
    725. Spinal and supraspinal changes in opioid mRNA expression are related to the onset of pain behaviors following excitotoxic spinal cord injury
    726. Effects of excitotoxic lesions of the substantia innominata, ventral and dorsal globus pallidus on visual discrimination acquisition, performance and reversal in the rat
    727. Effects of excitotoxic lesions of the rat prefrontal cortex on CREB regulation and presynaptic markers of dopamine and amino acid function in the nucleus accumbens
    728. Astroglial nitration after postnatal excitotoxic damage: correlation with nitric oxide sources, cytoskeletal, apoptotic and antioxidant proteins
    729. The neurotrophin receptors trkA, trkB and trkC are differentially regulated after excitotoxic lesion in rat striatum
    730. Recovery of song preferences after excitotoxic HVC lesion in female canaries
    731. Development of cholinergic amacrine cell stratification in the ferret retina and the effects of early excitotoxic ablation
    732. Association between inflammation and nigral neuronal damage following striatal excitotoxic lesion
    733. Behavioural sensitisation to repeated d-amphetamine: effects of excitotoxic lesions of the pedunculopontine tegmental nucleus
    734. Schedule-induced polydipsia and the nucleus accumbens: electrochemical measurements of dopamine efflux and effects of excitotoxic lesions in the core
    735. Selenium reduces the proapoptotic signaling associated to NF‐κB pathway and stimulates glutathione peroxidase activity during excitotoxic damage produced by …
    736. Cortical grafts prevent atrophy of cholinergic basal nucleus neurons induced by excitotoxic cortical damage
    737. NGF reduces striatal excitotoxic neuronal loss without affecting concurrent neuronal stress.
    738. excitotoxic lesions of the ventral anteroventral third ventricle and pressor responses to central sodium, ouabain and angiotensin II
    739. Short‐and long‐term survival of large neurons in the excitotoxic lesioned rat caudate nucleus: A light and electron microscopic study
    740. Cyclic GMP modulators and excitotoxic injury in cerebral cortical cultures
    741. Iodoacetate protects hippocampal neurons against excitotoxic and oxidative injury: involvement of heat‐shock proteins and Bcl‐2
    742. Status of the neonatal rat brain after NMDA‐induced excitotoxic injury as measured by MRI, MRS and metabolic imaging
    743. Heme oxygenase‐1 activity after excitotoxic injury: Immunohistochemical localization of bilirubin in neurons and astrocytes and deleterious effects of heme oxygenase …
    744. excitotoxic lesions of the gustatory thalamus spare simultaneous contrast effects but eliminate anticipatory negative contrast: evidence against a memory deficit.
    745. Release of the excitotoxic amino acids, glutamate and aspartate, from the isolated ischemic/anoxic rat heart
    746. excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: modulation by inhibition of nitric oxide synthesis
    747. Local and downstream effects of excitotoxic lesions in the rat medial prefrontal cortex on in vivo 1H-MRS signals
    748. Susceptibility to excitotoxic and metabolic striatal neurodegeneration in the mouse is genotype dependent
    749. No effect of apolipoprotein E on neuronal cell death due to excitotoxic and apoptotic agents in vitro and neonatal hypoxic ischaemia in vivo
    750. On the probabilistic nature of excitotoxic neuronal death in hippocampal neurons
    751. Ontogeny of excitotoxic injury to nicotinamide adenine dinucleotide phosphate diaphorase reactive neurons in the neonatal rat striatum
    752. Enprofylline protects motor neurons from in vitro excitotoxic challenge
    753. Degeneration of neurons in the thalamic reticular nucleus following transient ischemia due to raised intracranial pressure: excitotoxic degeneration mediated via non …
    754. Varied actions of proinflammatory cytokines on excitotoxic cell death in the rat central nervous system
    755. Neuropeptide changes following excitotoxic lesion of the insular cortex in rats
    756. The effect of excitotoxic lesions of the pedunculopontine tegmental nucleus on performance of a progressive ratio schedule of reinforcement
    757. Neurotrophin and GDNF family ligands promote survival and alter excitotoxic vulnerability of neurons derived from murine embryonic stem cells
    758. Differential fos expression following aspiration, electrolytic, or excitotoxic lesions of the perirhinal cortex in rats.
    759. … MPEP and the Na+ channel blocker riluzole show different neuroprotective profiles in reversing behavioral deficits induced by excitotoxic prefrontal cortex lesions
    760. Grafting of fetal CA3 neurons to excitotoxic, axon-sparing lesions of the hippocampal CA3 area in adult rats
    761. Inorganic Pi Increases Neuronal Survival in the Acute Early Phase Following excitotoxic/Oxidative Insults
    762. Adenovirus-mediated over-expression of interleukin-1 receptor antagonist reduces susceptibility to excitotoxic brain injury in perinatal rats
    763. Effects of chronic lithium treatment on ornithine decarboxylase induction and excitotoxic neuropathology in the rat
    764. excitotoxic lesions of the paraventricular hypothalamus: metabolic and cardiac effects
    765. Conditioning heat stress reduces excitotoxic and apoptotic components of oxygen‐glucose deprivation‐induced neuronal death in vitro
    766. excitotoxic hippocampal neuron loss following sustained electrical stimulation of the perforant pathway in the mouse
    767. Nitric oxide applications prior and simultaneous to potentially excitotoxic NMDA-evoked calcium transients: Cell death or survival
    768. Two phases of behavioral plasticity in rats following unilateral excitotoxic lesion of the hippocampus
    769. Protection of excitotoxic neuronal death by gluconate through blockade of N-methyl-D-aspartate receptors
    770. The effects of excitotoxic hippocampal lesions in rats on risperidone-and olanzapine-induced locomotor suppression
    771. Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative disease
    772. Postnatal development of functional properties of visual cortical cells in rats with excitotoxic lesions of basal forebrain cholinergic neurons
    773. Evaluation of quinolinic acid induced excitotoxic neurodegeneration in rat striatum by quantitative magnetic resonance imaging in vivo
    774. Age dependent sensitivity of the rat retina to the excitotoxic action ofN-methyl-D-aspartate
    775. excitotoxic injury stimulates glial fibrillary acidic protein mRNA expression in perinatal rat brain
    776. Transcription of the Huntington disease gene during the quinolinic acid excitotoxic cascade
    777. The impact of excitotoxic blockade on the evolution of injury following combined mechanical and hypoxic insults in primary rat neuronal culture
    778. … -elicited immediate early gene expression in neurons and glia of the hippocampus: novel patterns of FOS, JUN, and KROX expression following excitotoxic injury
    779. Aminooxyacetic acid produces excitotoxic brain injury in neonatal rats
    780. A Tau antisense oligonucleotide decreases neurone sensitivity to excitotoxic injury.
    781. Ischemia as an excitotoxic lesion: protection against hippocampal nerve cell loss by denervation
    782. Behavioral evaluation of the anti-excitotoxic properties of MK-801: comparison with neurochemical measurements
    783. Mitogen and stress response kinase‐1 (MSK1) mediates excitotoxic induced death of hippocampal neurones
    784. … properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy
    785. Non-spatial acquisition and retention deficits following small excitotoxic lesions within the hippocampus in monkeys
    786. Peptidyl α‐keto amide inhibitor of calpain blocks excitotoxic damage without affecting signal transduction events
    787. Differential DNA damage in response to the neonatal and adult excitotoxic hippocampal lesion in rats
    788. Effects of excitotoxic lesions of the nucleus basalis magnocellularis on conditioned taste aversion and inhibitory avoidance in the rat
    789. Effects of excitotoxic lesions of the gustatory thalamus on latent inhibition and blocking of conditioned taste aversion in rats
    790. Topical Insulin and Accumulation of excitotoxic and Other Amino Acids in Ischemic Rat Cerebral Cortex (44510)
    791. excitotoxic lesions of the lateral hypothalamus made by N-methyl-d-aspartate in the rat: behavioural, histological and biochemical analyses
    792. Fructose-1, 6-biphosphate prevents excitotoxic neuronal cell death in the neonatal mouse brain
    793. Glycine antagonist and NO synthase inhibitor protect the developing mouse brain against neonatal excitotoxic lesions
    794. excitotoxic damage of retinal glial cells depends upon normal neuron‐glial interactions
    795. Glucocorticoid treatment in an ischaemic-like excitotoxic model of periventricular leucomalacia in mice
    796. Retrograde degenerative changes in the substantia nigra pars compacta following an excitotoxic lesion of the striatum
    797. The effect of intravenous insulin on accumulation of excitotoxic and other amino acids in the ischemic rat cerebral cortex
    798. Striatopallidal neurons are selectively protected by neurturin in an excitotoxic model of Huntington’s disease
    799. 3-Nitropropionic acid produces indirect excitotoxic damage to rat striatum
    800. Behavioral effects of neonatal and adult excitotoxic lesions of the mediodorsal thalamus in the adult rat
    801. excitotoxic lesions of the entorhinal cortex leave gustatory within-event learning intact.
    802. Metabotropic glutamate receptor activation selectively limits excitotoxic damage in the intact neostriatum
    803. Enhanced locomotor activity in rats with excitotoxic lesions of the entorhinal cortex, a neurodevelopmental animal model of schizophrenia: behavioral and in vivo …
    804. Nitric oxide mediates the sustained opening of NMDA receptor-gated ionic channels which follows transient excitotoxic exposure in hippocampal slices
    805. Anti-porin antibodies prevent excitotoxic and ischemic damage to brain tissue
    806. Neurotrophic factor protection against excitotoxic neuronal death
    807. Thiokynurenates prevent excitotoxic neuronal death in vitro and in vivo by acting as glycine antagonists and as inhibitors of lipid peroxidation
    808. Apomorphine-induced dyskinesias after excitotoxic caudate-putamen lesions and the effects of neural transplantation in non-human primates
    809. Neonatal excitotoxic brain injury
    810. excitotoxic lesioning of the rat basal forebrain with S-AMPA: consequent mineralization and associated glial response
    811. GABA does not protect cerebro-cortical cultures against excitotoxic cell death
    812. Modulation of stress-induced dopamine release by excitotoxic damage of the entorhinal cortex in the rat
    813. Effect of nootropic Solcoseryl® on kainic acid-induced excitotoxic brain injury
    814. Bone marrow transplantation reveals roles for brain macrophage/microglia TNF signaling and nitric oxide production in excitotoxic neuronal death
    815. Increased proportion of high-affinity dopamine D2 receptors in rats with excitotoxic damage of the entorhinal cortex, an animal model of schizophrenia
    816. The calretinin‐containing mossy cells survive excitotoxic insult in the gerbil dentate gyrus. Comparison of excitotoxicity‐induced neuropathological changes in the …
    817. Changes in extracellular glutamate concentration after acute subdural haematoma in the rat—evidence for an “excitotoxic” mechanism?
    818. excitotoxic effect of kainic acid on chicken cochlear afferent neurons
    819. Long-lasting aberrant tubulovesicular membrane inclusions accumulate in developing motoneurons after a sublethal excitotoxic insult: a possible model for neuronal …
    820. A novel inhibitor of glutamate release reduces excitotoxic injury in vitro
    821. Role of tissue-derived plasminogen activator (t-PA) in an excitotoxic mouse model of neonatal white matter lesions
    822. Mineralization of the globus pallidus following excitotoxic lesions of the basal forebrain
    823. Protective effects of neurotrophin-4/5 and transforming growth factor-α on striatal neuronal phenotypic degeneration after excitotoxic lesioning with quinolinic acid
    824. In vivo microdialysis studies on the effects of decortication and excitotoxic lesions on kainic acid‐induced calcium fluxes, and endogenous amino acid release, in the …
    825. excitotoxic lesions of the pedunculopontine tegmental nucleus disinhibit orofacial behaviours stimulated by microinjections of d-amphetamine into rat ventrolateral …
    826. Competing approaches to excitotoxic neuroprotection by inert and catalytic antioxidant porphyrins
    827. excitotoxic lesions of the rhinal cortex in the baboon differentially affect visual recognition memory, habit memory and spatial executive functions
    828. excitotoxic Amino Acids Cause Appearance of Magnetic Resonance Spectroscopy‐Observable Zinc in Supervised Cortical Slices
    829. Adenoviral expression of CREB protects neurons from apoptotic and excitotoxic stress
    830. Cerebral metabolic consequences in the adult brain after neonatal excitotoxic lesions of the amygdala in rats
    831. Impairment of energy metabolism and excitotoxic cell death in Huntington disease.
    832. Administration of a non-NMDA antagonist, GYKI 52466, increases excitotoxic Purkinje cell degeneration caused by ibogaine
    833. Sustained, long-lasting inhibition of nitric oxide synthase aggravates the neural damage in some models of excitotoxic brain injury
    834. Topical glucose and accumulation of excitotoxic and other amino acids in ischemic cerebral cortex
    835. Dissociation between the excitatory and” excitotoxic” effects of quinolinic acid analogs on the striatal cholinergic interneuron.
    836. Learning impairments in monkeys with combined but not separate excitotoxic lesions of the anterior and mediodorsal thalamic nuclei
    837. excitotoxic neuronal death: mechanisms and clinical relevance
    838. Differential postreceptor signaling events triggered by excitotoxic stimulation of different ionotropic glutamate receptors in retinal neurons
    839. Evidence for synaptic proliferation, reorganization, and growth in the excitotoxic lesioned adult rat caudate nucleus
    840. Cortical changes in cholecystokinin mRNA are related to spontaneous pain behaviors following excitotoxic spinal cord injury in the rat
    841. Effect of perinatal alcohol exposure on ibotenic acid-induced excitotoxic cortical lesions in newborn hamsters
    842. 17β-Estradiol treatment retards excitotoxic delayed degeneration in substantia nigra reticulata neurons
    843. excitotoxic injury induces production of monocyte chemoattractant protein-1 in rat cortico-striatal slice cultures
    844. Comparison of the effects of the 5-HT 3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the …
    845. excitotoxic increase of xanthine dehydrogenase and xanthine oxidase in the rat olfactory cortex
    846. Parallel development of excitotoxic vulnerability to N-methyl-l-aspartate and kainate in dispersed cultures of the rat cerebral cortex
    847. Anti-excitotoxic activity of trimetazidine in the retina
    848. MK-801 is cytotoxic to microglia in vitro and its cytotoxicity is attenuated by glutamate, other excitotoxic agents and atropine: Possible presence of glutamate receptor …
    849. Effect of excitotoxic lesions of the neonatal ventral hippocampus on the immobility response in rats
    850. excitotoxic lesions of the rostral thalamic reticular nucleus do not affect the performance of spatial learning and memory tasks in the rat
    851. Glial expression of the 90‐kDa heat shock protein (HSP90) and the 94‐kDa glucose‐regulated protein (GRP94) following an excitotoxic lesion in the mouse …
    852. Effect of acamprosate on neonatal excitotoxic cortical lesions in in utero alcohol-exposed hamsters
    853. Disparity of cell swelling and rapid neuronal death by excitotoxic insults in rat hippocampal slice cultures
    854. Dissociation of effects of glutamate receptor antagonists on excitotoxic and hypoxic neuronal cell death in a novel rat cortical culture system
    855. Expression of c-fos mRNA is increased and related to dynorphin mRNA expression following excitotoxic spinal cord injury in the rat
    856. excitotoxic injury profiles of low-affinity kainate receptor agonists in cortical neuronal cultures
    857. Myosin Va is proteolysed in rat cerebellar granule neurons after excitotoxic injury
    858. Bursting properties of units in cat globus pallidus and entopeduncular nucleus: the effect of excitotoxic striatal lesions
    859. excitotoxic lesions of the rat striatum: different responses of kynurenine pathway enzymes during ontogeny
    860. Synergistic effects of tetrahydroaminoacridine and lithium on cholinergic function after excitotoxic basal forebrain lesions in rat
    861. Extrasynaptic NMDA receptors: mediators of excitotoxic cell death
    862. PET studies of domoic acid poisoning in humans: excitotoxic destruction of brain glutamatergic pathways, revealed in measurements of glucose metabolism by …
    863. Effects of excitotoxic striatal lesions on single unit activity in globus pallidus and entopeduncular nucleus of the cat
    864. excitotoxic and anti-excitotoxic mechanisms in neurological disease
    865. Bioenergetics and excitotoxicity: the weak excitotoxic hypothesis
    866. Distribution of the messenger RNA for the extracellularly regulated kinases 1, 2 and 3 in rat brain: effects of excitotoxic hippocampal lesions
    867. Strychnine protection against excitotoxic cell death in primary cultures of rat cerebral cortex